nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

11.09.2024 | Retinal Disorders

Risk factors for early and late retinal detachment after boston type I keratoprosthesis surgery

verfasst von: Eva Calpe, Jorge Fernández-Engroba, Gemma Julio, Josip Pavan, Clara Bonel, Rafael I. Barraquer

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the differential risk factors for retinal detachment (RD) after Boston Type 1 Keratoprosthesis (B1KPro) during the first year after surgery (early RD; ERD) and afterwards (late RD; LRD).

Methods

Retrospective cohort study of 94 eyes (90 patients) undergoing B1KPro implantation at Centro de Oftalmología Barraquer from June 2006 to July 2022 with a minimum follow-up of one year.

Results

The incidence of RD in the whole sample after B1KPro implantation was 29% (27/94), occurring in 21% of eyes (ERD; 20/94) the first year, and in 7% afterwards (LRD; 7/94). Hypotony was revealed as a significant risk factor for ERD (16/19 = 84%; OR = 14.5, P < 0.0001), together with aphakia (16/20 = 80%; OR = 5.9, P = 0.004), intraocular lens (IOL) removal (4/8 = 50%; OR = 6.2, P = 0.03), previous choroidal detachment (CD; 7/20 = 35%; OR = 35.5, P = 0.001) and previous pars plana vitrectomy (PPV; 15/20 = 75%; OR = 6.6, P = 0.006). Multivariate analysis included hypotony and PPV at any time as variables significantly associated with ERD occurrence. The occurrence of LRD was significantly related to peripheral retinal changes, detected few days before (4/6 = 66%; OR = 65, P < 0.0001).

Conclusion

Hypotony emerged as one of the main factors influencing ERD occurrence after B1KPro implantation. Additionally, previous CD, PPV, aphakia, and IOL removal should be considered to estimate the risk of postoperative retinal detachment. In contrast, peripheral retinal changes after B1KPro seem to be significantly related to LRD occurrence. This study reinforces the need for frequent intraocular pressure evaluation, and comprehensive periodic retinal assessment over time.

Key messages

What is known

Retinal detachment (RD) is a severe complication after Boston Type 1 Keratoprosthesis (B1KPro) implantation, resulting in a permanent reduction of visual acuity in a clinically relevant percentage of eyes.
The time of RD occurrence after B1KPro implantation differs in the literature but is reported to be more common within the first year. Previous aphakia, choroidal detachment, or RD repair, intraocular lens removal, vitritis, or history of Nd-YAG laser have been described as risk factors for RD after B1KPro surgery in samples with varying follow-ups.

What is new:

Multivariate analysis in the first year after B1KPro surgery showed hypotony and pars plana vitrectomy at any time as significant risk factors for early RD.
Late RD cases, occurring after one year following the B1KPro surgery, seem to be significantly related to peripheral retinal changes suffered a few days before loss of visual acuity and RD diagnosis.
It is plausible to think that risk factors for RD after B1KPro differ in short and long postoperative times.

Nur mit Berechtigung zugänglich

Aldave AJ, Kamal KM, Vo RC, Yu F (2009) The Boston type I keratoprosthesis improving outcomes and expanding indications. Ophthalmology 116(4):640–651. https://doi.org/10.1016/j.ophtha.2008.12.058CrossRefPubMed

Barber JC (1988) Keratoprosthesis: past and present. Int Ophthalmol Clin 28(1):103–109. https://doi.org/10.1097/00004397-198802820-00002CrossRefPubMed

Nonpassopon M, Niparugs M, Cortina MS (2020) Boston type 1 Keratoprosthesis: updated perspectives. Clin Ophthalmol 14:1189–1200. https://doi.org/10.2147/OPTH.S219270CrossRefPubMedPubMedCentral

Fadous R, Levallois-Gignac S, Vaillancourt L, Robert MC, Harissi-Dagher M (2015) The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure. Br J Ophthalmol 99(12):1664–1668. https://doi.org/10.1136/BJOPHTHALMOL-2014-306161CrossRefPubMed

Lázaro-Rodríguez V, Barraquer RI, Julio G, Bolaños J, Álvarez de Toledo J, de la Paz MF (2023) Anatomical and functional outcomes of Boston type I keratoprosthesis as primary penetrating corneal procedure in high-risk and non-high-risk cases. Graefes Arch Clin Exp Ophthalmol 261(1):161–170. https://doi.org/10.1007/S00417-022-05744-0CrossRefPubMed

Kanu LN, Niparugs M, Nonpassopon M, Karas FI, de la Cruz JM, Cortina MS (2020) Predictive factors of Boston type i keratoprosthesis outcomes: A long-term analysis. Ocul Surf 18(4):613–619. https://doi.org/10.1016/j.jtos.2020.07.012CrossRefPubMed

Bonnet C, Chehaibou I, Chen A, Bourges JL, Markovic D, Hubschman JP, Aldave AJ (2021) Postoperative posterior segment complications after Boston type 1 keratoprosthesis: incidence, risk factors, and intermediate-term outcomes. Retina 41(12):2499–2509. https://doi.org/10.1097/IAE.0000000000003233CrossRefPubMed

Petrou P, Banerjee PJ, Wilkins MR, Singh M, Eastlake K, Limb GA, Charteris DG (2017) Characteristics and vitreoretinal management of retinal detachment in eyes with Boston keratoprosthesis. Br J Ophthalmol 101(5):629–633. https://doi.org/10.1136/BJOPHTHALMOL-2016-308854CrossRefPubMed

Jardeleza MSR, Rheaume M-A, Chodosh J, Lane AM, Dohlman CH (2015) Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes. Digit J Ophthalmol 21(4):65–68. https://doi.org/10.5693/djo.01.2015.10.001CrossRef

10.

Szigiato A-A, Bostan C, Nayman T, Harissi-Dagher M (2020) Long-term visual outcomes of the Boston type I keratoprosthesis in Canada. Br J Ophthalmol 104(11):1601–1607. https://doi.org/10.1136/bjophthalmol-2019-315345CrossRefPubMed

11.

Ramos M, Kruger EF, Lashkari K (2002) Biostatistical analysis of pseudophakic and aphakic retinal detachments. Semin Ophthalmol 17(3-4):206–213. https://doi.org/10.1076/SOPH.17.3.206.14784CrossRefPubMed

12.

Aravena C, Yu F, Aldave AJ (2018) Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis. Cornea 37(1):3–10. https://doi.org/10.1097/ICO.0000000000001405CrossRefPubMed

13.

Lim JI, Machen L, Arteaga A, Karas FI, Hyde R, Cao D, Niec M, Vajaranant TS, Cortina MS (2018) Comparison of visual and anatomical outcomes of eyes undergoing type I Boston keratoprosthesis with combination pars plana vitrectomy with eyes without combination vitrectomy. Retina 38(Suppl 1):S125–S133. https://doi.org/10.1097/IAE.0000000000002036CrossRefPubMedPubMedCentral

14.

Bonnet C, Chehaibou I, McCannel CA, McCannel TA, Prasad PS, Kreiger AE, Schwartz SD, Aldave A, Hubschman J-P (2022) Retinal detachment in eyes with Boston type 1 keratoprosthesis. Retina 42(5):957–966. https://doi.org/10.1097/IAE.0000000000003389CrossRefPubMed

15.

Kaur G, Singh N (2023) Inflammation and retinal degenerative diseases. Neural Regen Res 18(3):513. https://doi.org/10.4103/1673-5374.350192CrossRefPubMed

16.

Wolvaardt E, Stevens S (2019) Measuring intraocular pressure. Community Eye Health 32(107):56–57PubMedPubMedCentral

17.

Da Silva F, Lira M (2022) Intraocular pressure measurement: a review. Surv Ophthalmol 67(5):1319–1331. https://doi.org/10.1016/J.SURVOPHTHAL.2022.03.001CrossRefPubMed

18.

Goldman DR, Hubschman J-P, Aldave AJ, Chiang A, Huang JS, Bourges J-L, Schwartz SD (2013) Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 33(3):532–541. https://doi.org/10.1097/IAE.0b013e3182641848CrossRefPubMed

19.

de la Paz MF, Salvador-Culla B, Charoenrook V, Temprano J, Álvarez de Toledo J, Grabner G, Michael R, Barraquer RI (2019) Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease. Ocular Surface 17(3):476–483. https://doi.org/10.1016/j.jtos.2019.04.006CrossRefPubMed

20.

Khair D, Daoud R, Harissi-Dagher M (2022) Retroprosthetic membrane formation in boston keratoprosthesis type 1: incidence, predisposing factors, complications, and treatment. Cornea 41(6):751–756. https://doi.org/10.1097/ICO.0000000000002883CrossRefPubMed

21.

Schubert HD (1996) Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous. Surv Ophthalmol 41(2):97–125. https://doi.org/10.1016/S0039-6257(96)80001-4CrossRefPubMed

22.

Wang Q, Thau A, Levin AV, Lee D (2019) Ocular hypotony: a comprehensive review. Surv Ophthalmol 64(5):619–638. https://doi.org/10.1016/j.survophthal.2019.04.006CrossRefPubMed

23.

Senthil S, Chary R, Ali MH, Choudhari NS, Garudadri CS (2022) Estimation of Goldmann applanation tonometer intraocular pressure (IOP) from scleral Schiotz IOP values in eyes with type-1 keratoprostheses. Br J Ophthalmol 106(4):480–484. https://doi.org/10.1136/bjophthalmol-2020-318121CrossRefPubMed

24.

Hoffmann EM, Aghayeva F, Wagner FM, Fiess A, Nagler M, Münzel T, Wild PS, Beutel ME, Schmidtmann I, Lackner KJ, Pfeiffer N, Schuster AK (2022) Intraocular pressure and its relation to ocular geometry: results from the Gutenberg health study. Invest Ophthalmol Vis Sci 63(1):40. https://doi.org/10.1167/iovs.63.1.40CrossRefPubMedPubMedCentral

25.

Tsui JC, Brucker AJ, Kim BJ, Kolomeyer AM (2023) Combined rhegmatogenous retinal and choroidal detachment. A systematic review. Retina 43(8):1226–1239. https://doi.org/10.1097/IAE.0000000000003770CrossRefPubMed

26.

Adelman RA, Parnes AJ, Michalewska Z, Ducournau D (2014) Clinical variables associated with failure of retinal detachment repair: The European vitreo-retinal society retinal detachment study report number 4. Ophthalmology 121(9):1715–1719. https://doi.org/10.1016/j.ophtha.2014.03.012CrossRefPubMed

27.

Daien V, Le Pape A, Heve D, Carriere I, Villain M (2015) Incidence, risk factors, and impact of age on retinal detachment after cataract surgery in France: a national population study. Ophthalmology 122(11):2179–2185. https://doi.org/10.1016/j.ophtha.2015.07.014CrossRefPubMed

28.

Perez VL, Leung EH, Berrocal AM, Albini TA, Parel JM, Amescua G, Alfonso EC, Ali TK, Gibbons A (2017) Impact of total pars plana vitrectomy on postoperative complications in aphakic, snap-on, type 1 Boston keratoprosthesis. Ophthalmology 124(10):1504–1509. https://doi.org/10.1016/j.ophtha.2017.04.016CrossRefPubMed

29.

Whitcup SM, Nussenblatt RB, Lightman SL, Hollander DA (2013) Inflammation in retinal disease. Int J Inflam (23):724648. https://doi.org/10.1155/2013/724648

30.

Hiscott P, Grierson I (1991) Subretinal membranes of proliferative vitreoretinopathy. Br J Ophthalmol 75(1):53. https://doi.org/10.1136/bjo.75.1.53CrossRefPubMedPubMedCentral

31.

Brubaker RF, Pederson JE (1983) Ciliochoroidal detachment. Surv Ophthalmol 27(5):281–289. https://doi.org/10.1016/0039-6257(83)90228-XCrossRefPubMed

32.

Fortingo N, Melnyk S, Sutton SH, Watsky MA, Bollag WB (2022) Innate immune system activation, inflammation and corneal wound healing. Int J Mol Sci 23(23):14933. https://doi.org/10.3390/IJMS232314933CrossRefPubMedPubMedCentral

33.

Luft N, Schumann RG, Dirisamer M, Kook D, Siedlecki J, Wertheimer C, Priglinger SG, Mayer WJ (2018) Wound healing, inflammation, and corneal ultrastructure after SMILE and femtosecond laser-assisted LASIK: a human ex vivo study. J Refract Surg 34(6):393–399. https://doi.org/10.3928/1081597X-20180425-02CrossRefPubMed

34.

Xu H, Chen M, Forrester JV, Lois N (2011) Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci 52(1):249–255. https://doi.org/10.1167/IOVS.10-6001CrossRefPubMed

35.

Črnej A, Omoto M, Dohlman TH, Gonzalez-Andrades M, Paschalis EI, Cruzat A, Vu THK, Doorenbos M, Chen DF, Dohlman CH, Dana R (2016) Effect of penetrating keratoplasty and keratoprosthesis implantation on the posterior segment of the eye. Invest Ophthalmol Vis Sci 57(4):1643–1648. https://doi.org/10.1167/iovs.15-17557CrossRefPubMedPubMedCentral

36.

Geoffrion D, Robert MC, Di PA, Koenekoop RK, Agoumi Y, Harissi-Dagher M (2021) Tear film cytokine profile of patients with the Boston keratoprosthesis type 1: comparing patients with and without Glaucoma. Invest Ophthalmol Vis Sci 62(4):20. https://doi.org/10.1167/IOVS.62.4.20CrossRefPubMedPubMedCentral

37.

Colby KA, Koo EB (2011) Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 22(4):267–273. https://doi.org/10.1097/ICU.0B013E3283477D0DCrossRefPubMed

38.

Botelho PJ, Congdon NG, Handa JT, Akpek EK (2006) Keratoprosthesis in high-risk pediatric corneal transplantation: first 2 cases. Arch Ophthalmol 124(9):1356–1357. https://doi.org/10.1001/ARCHOPHT.124.9.1356CrossRefPubMed

39.

Fung SSM, Jabbour S, Harissi-Dagher M, Tan RRG, Hamel P, Baig K, Ali A (2018) Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology 125(2):153–160. https://doi.org/10.1016/j.ophtha.2017.07.009CrossRefPubMed

40.

Elhusseiny AM, Traish A, Saeed HN (2022) Review: keratoprothesis in the pediatric population. Int Ophthalmol Clin 62(1):45–57. https://doi.org/10.1097/IIO.0000000000000392CrossRefPubMed

41.

Oke I, Hwang B, Heo H, Nguyen A, Lambert SR (2022) Risk factors for retinal detachment repair after pediatric cataract surgery in the United States. Ophthalmol Sci 2(4):100203. https://doi.org/10.1016/J.XOPS.2022.100203CrossRefPubMedPubMedCentral

42.

Böhm MRR, Tappeiner C, Breitbach MA, Zurek-Imhoff B, Heinz C, Heiligenhaus A (2017) Ocular hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Am J Ophthalmol 173:45–55. https://doi.org/10.1016/j.ajo.2016.09.018CrossRefPubMed

43.

Puodžiuviene E, Jokubauskiene G, Vieversyte M, Asselineau K (2018) A five-year retrospective study of the epidemiological characteristics and visual outcomes of pediatric ocular trauma. BMC Ophthalmol 18(1):10. https://doi.org/10.1186/s12886-018-0676-7CrossRefPubMedPubMedCentral

Titel: Risk factors for early and late retinal detachment after boston type I keratoprosthesis surgery
verfasst von: Eva Calpe
Jorge Fernández-Engroba
Gemma Julio
Josip Pavan
Clara Bonel
Rafael I. Barraquer
Publikationsdatum: 11.09.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-024-06613-8

Neu im Fachgebiet Augenheilkunde

Zirkulierende Tumorzellen bei uvealem Melanom

Aderhautmelanom
Leitthema

Die Erstbeschreibung von Tumorzellen in der Blutbahn erfolgte 1869 durch Thomas Ashworth. Dieser beschrieb in der Blutprobe eines metastasierten Krebskranken „cells identical with those of the cancer itself“ und postulierte, dass diese „may tend …

Elektrophysiologie in der Augenheilkunde

Visuell-evozierte-Potentiale
CME-Artikel

Mit elektrophysiologischen Untersuchungen kann man in der Augenheilkunde die Funktionalität der Neurone der Sehbahn untersuchen. Weil elektrophysiologische Ableitungen von der subjektiven Wahrnehmung und Antwort des Patienten unabhängig sind …

„Liquid biopsy“ bei Retinoblastom

Retinoblastom
Leitthema

Die „liquid biopsy“ spielt eine zunehmend wichtige Rolle bei der Diagnose und Behandlung des Retinoblastoms. Die Möglichkeit der sicheren und unkomplizierten Entnahme und Untersuchung von Kammerwasser aus der Vorderkammer trägt wesentlich zur …

Die „onkologische Spur“: zirkulierende Tumor-DNA beim Aderhautmelanom

Aderhautmelanom
Leitthema

In Körperflüssigkeiten wurde zirkulierende Desoxyribonukleinsäure (DNA) bereits vor mehr als 75 Jahren beschrieben [ 19 ]. Aber erst durch die eindrucksvolle technische Weiterentwicklung im Bereich der Nukleinsäureanalyse in den letzten Jahren ist …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen